|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-1-2
|
|
pubmed:abstractText |
This study compared the incidence of acute or chronic rejection and adverse events in lung transplant patients receiving induction basiliximab versus controls not receiving treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3996-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16386608-Adult,
pubmed-meshheading:16386608-Aged,
pubmed-meshheading:16386608-Antibodies, Monoclonal,
pubmed-meshheading:16386608-Female,
pubmed-meshheading:16386608-Graft Rejection,
pubmed-meshheading:16386608-Humans,
pubmed-meshheading:16386608-Immunosuppressive Agents,
pubmed-meshheading:16386608-Lung Diseases,
pubmed-meshheading:16386608-Lung Transplantation,
pubmed-meshheading:16386608-Male,
pubmed-meshheading:16386608-Methylprednisolone,
pubmed-meshheading:16386608-Middle Aged,
pubmed-meshheading:16386608-Recombinant Fusion Proteins,
pubmed-meshheading:16386608-Survival Analysis,
pubmed-meshheading:16386608-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Comparative study of basiliximab treatment in lung transplantation.
|
|
pubmed:affiliation |
Juan Canalejo Hospital, La Coruña, Spain. jmborro@canalejo.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Controlled Clinical Trial
|
